Auxellence Announces Re-Pricing of Private Placement Financing and Receipt of $175,000 of Funds


Follow this company

Companies Mentioned

CNSX:AID
05/06/2014 [ACCESSWIRE]

VANCOUVER, BC / ACCESSWIRE / Tuesday May 6th, 2014 / Auxellence Health Corporation (CSE:AID) (the "Company" or "Auxellence") today announces that it has re-priced the previously announce private placement financing from $0.15 to $0.10. In addition, the company announces that it intends to raise a minimum of $200,000 through this non-brokered private placement for commons shares and/or convertible debt. The company has received $50,000 from one director of the company and $125,000 from an external party for a total of $175,000 towards the private placement. The funds are being applied towards working capital for the company.

Contact:

Sydney Au, President & CEO

Auxellence Health Corporation

Email: sydau945@gmail.com

Phone: (604) 780-3311

About Auxellence Health Corporation

Auxellence is a health technology company that aims to provide high-level online personal health services to consumers, providers and suppliers of OTC (Over-The-Counter) health care products and services, including refining the effectiveness of prescribing services to the OTC (Over-The-Counter) consumer pharmaceutical and natural health industry. The Company is integrating innovative therapeutic and diagnostic (theragnostic) devices (hardware components), along with an interactive Expert System and Recommender "PRESCRIPTOR" engine (software platform) to acquire physiological data for personalized medicine and health solutions to everyday health issues (initially targeting weight management and skin health conditions (acne)).

Disclaimer for Forward-Looking Information Statements in this press release regarding the Company which are not historical facts are "forward-looking statements" that involve risks and uncertainties. Such information can generally be identified by the use of forwarding-looking wording such as "may", "will", "expect", "estimate", "anticipate", "intend", "believe" and "continue" or the negative thereof or similar variations. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated in such statements due to factors. Except as required by law, the Company does not intend to update any changes to such statements. Although Management believes that the expectations represented in such forward-looking statements are reasonable, there can be no assurance that such expectations will prove to be correct. This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein and accordingly undue reliance should not be put on such. Neither Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

THIS PRESS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

COMMENTS

Leave a comment...
 * 

Your Name
 *